INTRAPERITONEAL RECOMBINANT FACTOR VIII IN HEMOPHILIA A

血友病 A 中的腹腔内重组因子 VIII

• 批准号: 6244930
• 负责人: DARLA K LILES
• 金额: $ 1.34万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-01-06 至 1997-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6244930
• 关键词: blood disorder chemotherapy; clinical research; coagulation factor VIII; drug administration routes; drug screening /evaluation; hemophilia As; human subject; human therapy evaluation; recombinant proteins

The study is being carried out to determine the efficacy of factor VIII when given by routes other than intravenous. This will provide information on other potential routes of administration which can be used in patients who have inadequate venous access as well as give us information on absorption profiles of factor VIII that can be utilized in future gene therapy work.

正在进行该研究以确定因子 VIII 的功效 当通过静脉注射以外的途径给药时。 这将提供 其他潜在给药途径的信息 用于静脉通路不足的患者，并为我们提供 有关可利用的因子 VIII 吸收概况的信息 在未来的基因治疗工作中。